The role of biochemical diagnostics when determining the severity of disease in COVID-19 patients

31 May 2020

In this application note, Radiometer discusses the role of biochemical diagnostics when determining the severity of disease in COVID-19 patients. This application note highlights how there are elevated levels of fibrin-related markers, D-dimer, and Fibrinogen Degradation Products in COVID-19 related deaths and discusses how these can be used to determine the severity of the disease.

AQT90 FLEX immunoassay analyzer

Radiometer

Point-of-care biomarker testing made simple with the AQT90 FLEX immunoassay analyzer Biomarker menu: TnI, TnT, CKMB, Myo, NT-proBNP, PCT, CRP, D-Dimer, βhCG 

(0)

Links

Tags